Loading...
Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care
BACKGROUND: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and death. Drug use remains the significant cause of new infections in the European Union, with estimates of HCV antibody prevalence among people who inject drugs ranging from 5% to 90% in 29 European countries....
Na minha lista:
| Udgivet i: | JMIR Res Protoc |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
JMIR Publications
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006011/ https://ncbi.nlm.nih.gov/pubmed/29866641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.9043 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|